Q1 2025 Earnings Call Transcript February 13, 2025 Applied DNA Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.56 EPS, expectations were $-0.32. Operator: Good day, and welcome to ...
Q1 2025 Management View The company announced a strategic restructuring to focus on its LineaRx subsidiary, exiting the DNA Tagging and Security Products and Services segment. This move is expected to ...
PCR is effective at making blunt-ended DNA, which is useful for both IVT templates and CRISPR donor DNA. The CRISPR market, ...
Announces Exit of DNA Tagging and Security Products and Services Business Segment - - Workforce Reduction of 20% of Headcount ...
InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary ...
Of note, JN.1-based monovalent mRNA vaccines (JN.1 MV) were also approved in the EU, UK, and Japan in 2024. Clinical studies of JN.1 MVs have led to robust serum neutralising titers against JN.1 ...
5′CapQ can offer relative quantification without a standard as a function of in vitro transcription (IVT) or enzymatic capping optimization to maximize yield of intact mRNA or can offer absolute ...
Investigational mRNA vaccines are manufactured for individuals based on the specific molecular features of their tumours. Credit: FatCamera via Getty Images. The UK’s drug regulatory authority has ...
But the bill also would prohibit mRNA vaccines, like those developed by Pfizer and Moderna to combat COVID-19, Shippy told the Idaho Statesman. Vaccines that use mRNA technology are not gene ...
Ahead of his Senate confirmation hearing this week, Robert F. Kennedy Jr., President Donald Trump’s nominee to lead the Department of Health and Human Services (HHS), has said he’s not “anti ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results